Primary Site >> Colorectal Cancer

Gene >> FXYD3

Journal: Cancer Res. 2003 Aug 1;63(15):4602-6.
Title: Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
Author: Maxwell, Pamela J|Longley, Daniel B|Latif, Tariq|Boyer, John|Allen, Wendy|Lynch, Maria|McDermott, Ultan|Harkin, D Paul|Allegra, Carmen J|Johnston, Patrick G
PMID: 12907638
Journal: Biol Pharm Bull. 2007 Apr;30(4):648-54.
Title: Interaction of Mat-8 (FXYD-3) with Na+/K+-ATPase in colorectal cancer cells.
Author: Arimochi, Junko|Ohashi-Kobayashi, Ayako|Maeda, Masatomo
PMID: 17409496
Journal: Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):137-42.
Title: Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
Author: Loftas, Per|Onnesjo, Sofia|Widegren, Emma|Adell, Gunnar|Kayed, Hany|Kleeff, Jorg|Zentgraf, Hanswalter|Sun, Xiao-Feng
PMID: 19289258
Journal: Chemotherapy. 2009;55(6):407-13.
Title: Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers.
Author: Widegren, Emma|Onnesjo, Sofia|Arbman, Gunnar|Kayed, Hany|Zentgraf, Hanswalter|Kleeff, Jorg|Zhang, Hong|Sun, Xiao-Feng
PMID: 19955746
Journal: J Pathol. 2012 Dec;228(4):459-70.
Title: Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
Author: Meding, Stephan|Balluff, Benjamin|Elsner, Mareike|Schone, Cedrik|Rauser, Sandra|Nitsche, Ulrich|Maak, Matthias|Schafer, Alexander|Hauck, Stefanie M|Ueffing, Marius|Langer, Rupert|Hofler, Heinz|Friess, Helmut|Rosenberg, Robert|Walch, Axel
PMID: 22430872
Journal: Biomarkers. 2012 Jun;17(4):362-71.
Title: Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.
Author: Kiyamova, Ramziya|Garifulin, Oleg|Gryshkova, Vitalina|Kostianets, Olga|Shyian, Maksym|Gout, Ivan|Filonenko, Valeriy
PMID: 22612312
Journal: Oncotarget. 2015 Sep 8;6(26):22996-3007.
Title: MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer.
Author: Simmer, Femke|Venderbosch, Sabine|Dijkstra, Jeroen R|Vink-Borger, Elisa M|Faber, Claudius|Mekenkamp, Leonie J|Koopman, Miriam|De Haan, Anton F|Punt, Cornelis J|Nagtegaal, Iris D
PMID: 26392389